We describe two patients whose initial presentation of systemic lupus erythematosus (SLE)
was accompanied by haemorrhagic episodes and significant coagulopathy. Further …

Lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) is a rare acquired disorder
caused by prothrombin antibodies. The disease is most common in the pediatric age group …

The lupus anticoagulant-hypoprothrombinemia syndrome (LAHS)—the association of
acquired factor II deficiency and lupus anticoagulant—is a rare disease drastically different …

Patients with lupus anticoagulant (LA), a thrombotic risk factor, along with decreased
prothrombin (FII) activity are classified as lupus anticoagulant-hypoprothrombinemia …

Discussion Since its first description by Rapaport in 1960 [1], the lupus anticoagulant-
hypoprothrombinemia syndrome (HLAS) has been well documented. It is a rare event: at the …

Lupus anticoagulant, also known as lupus antibody, is generally associated with thrombosis
rather than bleeding events. Lupus anticoagulant-hypoprothrombinemia syndrome in …

Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare disorder
characterized by a bleeding tendency due to factor II deficiency associated with the …

Hypoprothrombinemia associated with a lupus anticoagulant (LA) was first reported in the
literature over 50 years ago. The hypoprothrombinemia‐lupus anticoagulant syndrome …

Lupus anticoagulants (LA) are part of a large group of autoanti-bodies thought to be directed
against at least two phospholipid-binding plasma proteins, pz-glycoprotein I and …

A 17-year-old girl was admitted to our department with a hemorrhagic syndrome due to a
serious coagulopathy; prothrombin time (PT) INR was 2.46 and the activated partial …